Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

Uyttenhove, Catherine, Pilotte, Luc, Théate, Ivan, Stroobant, Vincent, Colau, Didier, Parmentier, Nicolas, Boon, Thierry, Van den Eynde, Benoît J·2003·Nature Medicine

DOI 10.1038/nm934

Cited by (1,003)

Items 901–1,000 of 1,003

Different immune correlates associated with tumor progression and regression: implications for prevention and treatment of cancer
Duane H. Hamilton, Peter A. Bretscher · 2008 · Cancer Immunology Immunotherapy
Plasmacytoid dendritic cells and their therapeutic activity in cancer
Aldo Pinto, Alessia Rega, Timothy R. Crother, Rosalinda Sorrentino · 2012 · OncoImmunology
Palladium-Nanoparticle-Catalyzed 1,7-Palladium Migration Involving C–H Activation, Followed by Intramolecular Amination: Regioselective Synthesis of N1-Arylbenzotriazoles and an Evaluation of Their Inhibitory Activity toward Indoleamine 2,3-Dioxygenase
Koji Takagi, Mohammad Al‐Amin, Naoyuki Hoshiya, Johan Wouters, Hiroshi Sugimoto, Yoshitsugu Shiro, Hayato Fukuda, Satoshi Shuto, Mitsuhiro Arisawa · 2014 · The Journal of Organic Chemistry
Improved Radiosynthesis and Biological Evaluations of L- and D-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of IDO-Mediated Kynurenine Pathway of Tryptophan Metabolism
Yangchun Xin, Hancheng Cai · 2016 · Molecular Imaging and Biology
Aspects of Tryptophan and Nicotinamide Adenine Dinucleotide in Immunity: A New Twist in an Old Tale
Héctor Rodríguez Cetina Biefer, Anju Vasudevan, Abdallah Elkhal · 2017 · International Journal of Tryptophan Research
Inhibition Mechanisms of Human Indoleamine 2,3 Dioxygenase 1
Ariel Lewis-Ballester, Shay Karkashon, Dipanwita Batabyal, T.L. Poulos, Syun‐Ru Yeh · 2018 · Journal of the American Chemical Society
Antitumor Effect of Fluoxetine on Chronic Stress-Promoted Lung Cancer Growth via Suppressing Kynurenine Pathway and Enhancing Cellular Immunity
Zhen Yang, Zhuman Li, Zhijun Guo, Yu Ren, Ting Zhou, Zhijun Xiao, Jingjing Duan, Chuangchuang Han, Yuanchi Cheng, Feng Xu · 2021 · Frontiers in Pharmacology
Metabolic mechanisms of cancer-induced inhibition of immune responses
Antonella Viola, Vincenzo Bronte · 2007 · Seminars in Cancer Biology
Sentinel node lymphocytes: tumour reactive lymphocytes identified intraoperatively for the use in immunotherapy of colon cancer
Per Marits, Mona Karlsson, Kjell Dahl, Per-Anders Larsson, Alkwin Wanders, Magnus Thörn, Ola Winqvist · 2006 · British Journal of Cancer
Therapeutics targeting tumor immune escape: Towards the development of new generation anticancer vaccines
Simone Mocellin M. D, Donato Nitti · 2007 · Medicinal Research Reviews
Spinal Metastases and the Evolving Role of Molecular Targeted Therapy, Chemotherapy, and Immunotherapy
Elena I. Fomchenko, James C. Bayley, Christopher A Alvarez-Breckenridge, Laurence D. Rhines, Claudio Esteves Tatsui · 2022 · Neurospine
Targeting Multiple-Myeloma-Induced Immune Dysfunction to Improve Immunotherapy Outcomes
Sergio Rutella, Franco Locatelli · 2012 · Clinical and Developmental Immunology
Molecular imaging and targeted therapies
David L. Morse, Robert J. Gillies · 2010 · Biochemical Pharmacology
Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunity
Daniel E. Speiser, Pedro J. Romero · 2010 · Seminars in Immunology
Anti-regulatory T cells
Mads Hald Andersen · 2016 · Seminars in Immunopathology
Cognate Nonlytic Interactions between CD8+ T Cells and Breast Cancer Cells Induce Cancer Stem Cell–like Properties
Roland Gregor Stein, Stefan Ebert, Laura Schlahsa, Claus Jürgen Scholz, Matthias Braun, Petra Hauck, Evi Horn, Camelia‐Maria Monoranu, Vincent Thiemann, Michael P. Wustrow et al. · 2019 · Cancer Research
Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors
Jan‐Michael Werner, Philipp Lohmann, Gereon R. Fink, Karl‐Josef Langen, Norbert Galldiks · 2020 · Molecules
Hodgkin Disease and the Role of the Immune System
Alana A. Kennedy‐Nasser, Patrick J. Hanley, Catherine M. Bollard · 2011 · Pediatric Hematology and Oncology
Antioxidant Food Supplements and Obesity-Related Inflammation
Harald Mangge, Kelli Leilani Summers, Gunter Almer, Ruth Prassl, Daniel Weghuber, Wolfgang Johann Schnedl, Dietmar Fuchs · 2013 · Current Medicinal Chemistry
IDO Downregulation Induces Sensitivity to Pemetrexed, Gemcitabine, FK866, and Methoxyamine in Human Cancer Cells
Saman Maleki Vareki, Di Chen, Christine Di Cresce, Peter J. Ferguson, René Figueredo, Macarena Pampillo, Mateusz Rytelewski, Mark David Vincent, Wei‐Ping Min, Xiufen Zheng et al. · 2015 · PLoS ONE
Resveratrol suppresses tumor progression via the regulation of indoleamine 2,3-dioxygenase
Kyung Tae Noh, Seung Hoon Chae, Sung Hak Chun, In Duk Jung, Hyun Kyu Kang, Yeong‐Min Park · 2013 · Biochemical and Biophysical Research Communications
Thiosemicarbazide, a fragment with promising indolamine-2,3-dioxygenase (IDO) inhibition properties
Silvia Serra, Laurence Moineaux, Christelle Vancraeynest, Bernard Masereel, Johan Wouters, Lionel Pochet, Raphaël Frédérick · 2014 · European Journal of Medicinal Chemistry
Implication of indolamine 2,3 dioxygenase in the tolerance toward fetuses, tumors, and allografts
Sophie Dürr, Vincent Kindler · 2013 · Journal of Leukocyte Biology
Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry
Alice Coletti, Francesco Antonio Greco, Daniela Dolciami, Emidio Camaioni, Roccaldo Sardella, Maria Teresa Pallotta, Claudia Volpi, Ciriana Orabona, Ursula Grohmann, Antonio Macchiarulo · 2017 · MedChemComm
Metabolomic and Lipidomic Profiling of Bone Marrow Plasma Differentiates Patients with Monoclonal Gammopathy of Undetermined Significance from Multiple Myeloma
Wilson I. Gonsalves, Katarzyna A. Broniowska, Erik Jessen, Xuan-Mai T. Petterson, Alexander Graham Bush, Jaimee Gransee, Martha Q. Lacy, Taro Hitosugi, Shaji Kunnathu Kumar · 2020 · Scientific Reports
Unique Sulfur–Aromatic Interactions Contribute to the Binding of Potent Imidazothiazole Indoleamine 2,3-Dioxygenase Inhibitors
Yi‐Hui Peng, Fang-Yu Liao, Chen‐Tso Tseng, Ramajayam Kuppusamy, An-Siou Li, Chi-Han Chen, Yu-Shiou Fan, Sing-Yi Wang, Mine-Hsine Wu, Ching-Cheng Hsueh et al. · 2020 · Journal of Medicinal Chemistry
Visualizing CTL/melanoma cell interactions: multiple hits must be delivered for tumour cell annihilation
Íris Caramalho, Mustapha Faroudi, Elisabetta Padovan, Sabina Müller, Salvatore Valitutti · 2008 · Journal of Cellular and Molecular Medicine
Prognostic role of indoleamine 2,3-dioxygenase in endometrial carcinoma
Renske A. de Jong, Ido P. Kema, Annemarie Boerma, H. Marike Boezen, Johannes J.L. van der Want, Marloes J.M. Gooden, Harry Hollema, Hans W. Nijman · 2012 · Gynecologic Oncology
The role of T-regulatory cells in pregnancy and cancer
Jacek, R. Wilczynski · 2007 · Frontiers in bioscience
Inhibition of allogeneic T‐cell responses by dendritic cells expressing transduced indoleamine 2,3‐dioxygenase
Naoko Funeshima, Masayuki Fujino, Yusuke Kitazawa, Yuko Hara, Yoshiaki Hara, Kou Hayakawa, Torayuki Okuyama, Hiromitus Kimura, Xiao‐Kang Li · 2004 · The Journal of Gene Medicine
Superior antitumor immunotherapy efficacy of kynureninase modified CAR-T cells through targeting kynurenine metabolism
Quanjun Yang, Juan Hao, Mengyi Chi, Yaxian Wang, Bo Xin, Jinglu Huang, Jin Lu, Jie Li, Xipeng Sun, Chunyan Li et al. · 2022 · OncoImmunology
Microbial metabolites are involved in tumorigenesis and development by regulating immune responses
Jiahui Liu, Ruxian Tian, Caiyu Sun, Ying Guo, Lei Dong, Yumei Li, Xicheng Song · 2023 · Frontiers in Immunology
The specific targeting of immune regulation: T-cell responses against Indoleamine 2,3-dioxygenase
Mads Hald Andersen · 2012 · Cancer Immunology Immunotherapy
The potential of targeting indoleamine 2,3-dioxygenase for cancer treatment
Johanna Maria Gostner, Kathrin Becker, Florian Überall, Dietmar Fuchs · 2015 · Expert Opinion on Therapeutic Targets
Suppression of azoxymethane‐induced colonic preneoplastic lesions in rats by 1‐methyltryptophan, an inhibitor of indoleamine 2,3‐dioxygenase
Kengo Ogawa, Takeshi Hara, Masahito Shimizu, Soranobu Ninomiya, Junji Nagano, Hiroyasu Sakai, Masato Hoshi, Hiroyasu Ito, Hisashi Tsurumi, Kuniaki Saito et al. · 2012 · Cancer Science
Shaping the Glioma Immune Microenvironment Through Tryptophan Metabolism
Michael Platten, Michael Weller, Wolfgang Wick · 2012 · CNS Oncology
Ipilimumab: From Preclinical Development to Future Clinical Perspectives in Melanoma
Paul Letendre, Varun Monga, Mohammed M. Milhem, Yousef Zakharia · 2016 · Future Oncology
Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions
Petr Tomek, Brian D. Palmer, Jack U. Flanagan, Chuanwen Sun, Emma Lloyd Raven, Lai‐Ming Ching · 2016 · European Journal of Medicinal Chemistry
The role of metabolic reprogramming in T cell fate and function.
Nikolaos Patsoukis, Kankana Bardhan, Jessica D. Weaver, Christoph Herbel, Pankaj Seth, Lequn Li, Vassiliki A. Boussiotis · 2016 · PubMed
A recombinant oncolytic Newcastle virus expressing MIP-3α promotes systemic antitumor immunity
Feng‐Ying Huang, Jinyan Wang, Shu-Zhen Dai, Yingying Lin, Yan Sun, Liming Zhang, Zhuoxuan Lu, Rong Yue Cao, Guang‐Hong Tan · 2020 · Journal for ImmunoTherapy of Cancer
Exosomes-carrying Epstein-Barr virus-encoded small RNA-1 induces indoleamine 2, 3-dioxygenase expression in tumor-infiltrating macrophages of oral squamous-cell carcinomas and suppresses T-cell activity by activating RIG-I/IL-6/TNF-α pathway
Ati Burassakarn, Sawarot Srisathaporn, Chamsai Pientong, Weerayut Wongjampa, Patravoot Vatanasapt, Natcha Patarapadungkit, Tipaya Ekalaksananan · 2021 · Oral Oncology
In Vitro Evaluation of CD276-CAR NK-92 Functionality, Migration and Invasion Potential in the Presence of Immune Inhibitory Factors of the Tumor Microenvironment
Stefan Grote, Guillermo Ureña-Bailén, Kenneth Chun-Ho Chan, Caroline Baden, Markus Mezger, Rupert Handgretinger, Sabine Schleicher · 2021 · Cells
Investigational PET tracers in neuro-oncology—What’s on the horizon? A report of the PET/RANO group
Norbert Galldiks, Karl‐Josef Langen, Nathalie L. Albert, Ian G. Law, Michelle M. Kim, Javier E. Villanueva-Meyer, Riccardo Soffietti, Patrick Yung Wen, Michael Weller, J. C. Tonn · 2022 · Neuro-Oncology
Immune regulatory effects of simvastatin on regulatory T cell-mediated tumour immune tolerance
Sung Yong Lee, J Y Moon, Haneul Choi, H O Kim, Gyu Young Hur, K H Jung, S. Y. Lee, J H Kim, C Shin, Joongwon Shim et al. · 2010 · Clinical & Experimental Immunology
Cyclooxygenase-2 (COX-2) Inhibition Constrains Indoleamine 2,3-Dioxygenase 1 (IDO1) Activity in Acute Myeloid Leukaemia Cells
Maria Grazia Iachininoto, Eugenia Rosa Nuzzolo, Giuseppina Bonanno, Andrea Mariotti, Annabella Procoli, Franco Locatelli, Raimondo DE CRISTOFARO, Sergio Rutella · 2013 · Molecules
Indoleamine 2,3-dioxygenase and immune tolerance in ovarian cancer
Kazuhiko Ino · 2010 · Current Opinion in Obstetrics & Gynecology
Indoleamine 2,3 dioxygenase and human leucocyte antigen‐G inhibit the T‐cell alloproliferative response through two independent pathways
Solène Le Rond, Álvaro González, Ana S. L. Gonzalez, Edgardo Delfino Carosella, Nathalie Rouas‐Freiss · 2005 · Immunology
IDO inhibits T-cell function through suppressing Vav1 expression and activation
Runmei Li, Feng Wei, Jinpu Yu, Hui Li, Xiubao Ren, Xiubao Ren · 2009 · Cancer Biology & Therapy
Discovery of novel hydroxyamidine based indoleamine 2,3-dioxygenase 1 (IDO1) and thioredoxin reductase 1 (TrxR1) dual inhibitors
Ji Zhou, Lizhen Yu, Yali Fan, Ci-Hao Guo, Xiaomei Lv, Zhiyin Zhou, Huidan Huang, Dong‐Dong Miao, Shengpeng Zhang, Xinyu Li et al. · 2022 · European Journal of Medicinal Chemistry
Immunomodulatory effect of locoregional therapy in the tumor microenvironment
Lin Xie, Zhiqiang Meng · 2023 · Molecular Therapy
Microbial modulation of tryptophan metabolism links gut microbiota to disease and its treatment
Pengfei Zhao, Yuqi Chen, Shuyu Zhou, Fei Li · 2025 · Pharmacological Research
The learned safety paradigm as a mouse model for neuropsychiatric research
Daniela D. Pollak, Francisco J. Monje, Gert Lübec · 2010 · Nature Protocols
Indol-2-yl ethanones as novel indoleamine 2,3-dioxygenase (IDO) inhibitors
Eduard Dolušić, Pierre Larrieu, Sébastien Blanc, Frédéric Sapunaric, Bernadette Norberg, Laurence Moineaux, Delphine Colette, Vincent Stroobant, Luc Pilotte, Didier Colau et al. · 2010 · Bioorganic & Medicinal Chemistry
Increased tryptophan uptake on PET has strong independent prognostic value in patients with a previously treated high-grade glioma
D. O. Kamson, Sandeep Mittal, Natasha L. Robinette, Otto Muzik, William J. Kupsky, Geoffrey R. Barger, Csaba Juhász · 2014 · Neuro-Oncology
Until Death Do Us Part: Necrosis and Oxidation Promote the Tumor Microenvironment
Ramin Lotfi, Christof Kaltenmeier, Michael T. Lotze, Christoph Bergmann · 2016 · Transfusion Medicine and Hemotherapy
TDO as a therapeutic target in brain diseases
Chengpeng Yu, Zezheng Pan, Daya Luo · 2016 · Metabolic Brain Disease
Tryptophanyl-tRNA synthetase mediates high-affinity tryptophan uptake into human cells
Miki Miyanokoshi, Takumi Yokosawa, Keisuke Wakasugi · 2018 · Journal of Biological Chemistry
Nanomaterial‐mediated platinum drug‐based combinatorial cancer therapy
Zhiqin Deng, Na Wang, Fujin Ai, Zhigang Wang, Guangyu Zhu · 2020 · Open Research (University of Surrey)
Charge convertible biomimetic micellar nanoparticles for enhanced melanoma-targeted therapy through tumor cells and tumor-associated macrophages dual chemotherapy with IDO immunotherapy
Kaipei Luo, Yunfei Lian, Min Zhang, Hua Yu, Guangji Wang, Juan Li · 2021 · Chemical Engineering Journal
Interdisciplinary insights into the link between gut microbiome and gastric carcinogenesis—what is currently known?
Karolina Kaźmierczak-Siedlecka, Agnieszka Daca, Giandomenico Roviello, Martina Catalano, Karol Połom · 2021 · Gastric Cancer
Immune modulation in corneal transplantation
Hongmei Fu, Frank Larkin, Andrew J.T. George · 2008 · Transplantation Reviews
Tryptophan PET in pretreatment delineation of newly-diagnosed gliomas: MRI and histopathologic correlates
David Olayinka. Kamson, Csaba Juhász, Amy Buth, William J. Kupsky, Geoffrey R. Barger, Pulak K. Chakraborty, Otto Muzik, Sandeep Mittal · 2013 · Journal of Neuro-Oncology
Spectroscopic Studies of Ligand and Substrate Binding to Human Indoleamine 2,3-Dioxygenase
Changyuan Lu, Yu Hong Lin, Syun‐Ru Yeh · 2010 · Biochemistry
4,5-Disubstituted 1,2,3-triazoles: Effective Inhibition of Indoleamine 2,3-Dioxygenase 1 Enzyme Regulates T cell Activity and Mitigates Tumor Growth
Subhankar Panda, Nirmalya Pradhan, Soumya Chatterjee, Sudhir Morla, Abhishek Saha, Ashalata Roy, Sachin Kumar, Arindam Bhattacharyya, Debasis Manna · 2019 · Scientific Reports
Immunotherapy in acute myeloid leukemia
Dolores A. Grosso, Rosemary Hess, Mark Adam Weiss · 2015 · Cancer
S-Benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase
Kenji Matsuno, Kazushige Takai, Yoshinobu Isaka, Yuka Unno, Masayuki Sato, Osamu Takikawa, Akira Asai · 2010 · Bioorganic & Medicinal Chemistry Letters
High-Throughput Fluorescence-Based Screening Assays for Tryptophan-Catabolizing Enzymes
Nicole Willemsen‐Seegers, Antoon M. van Doornmalen, Joost C.M. Uitdehaag, Jos de Man, Rogier C. Buijsman, Guido J.R. Zaman · 2014 · SLAS DISCOVERY
The evolving role of dendritic cells in cancer therapy
Elizabeth J. Ilett, RJD Prestwich, Alan A. Melcher · 2010 · Expert Opinion on Biological Therapy
Malignant melanoma—The cradle of anti-neoplastic immunotherapy
Kristian Michael Koller, Wenge Wang, Todd D. Schell, Eugene M. Cozza, Kathleen M. Kokolus, Rogerio Izar Neves, Heath B. Mackley, Colette R. Pameijer, Anna Mary Leung, Bryan E. Anderson et al. · 2016 · Critical Reviews in Oncology/Hematology
NUDT2 Disruption Elevates Diadenosine Tetraphosphate (Ap4A) and Down-Regulates Immune Response and Cancer Promotion Genes
Andrew S. Marriott, Olga Vasieva, Yongxiang Fang, Nikki A. Copeland, Alexander G. McLennan, Nigel J. Jones · 2016 · PLoS ONE
Combinatorial antitumor effects of indoleamine 2,3-dioxygenase inhibitor NLG919 and paclitaxel in a murine B16-F10 melanoma model
Xiangjing Meng, Guangying Du, Liang Ye, Shanyue Sun, Qiaofeng Liu, Hongbo Wang, Wenyan Wang, Zimei Wu, Jingwei Tian · 2017 · International Journal of Immunopathology and Pharmacology
Integration of Nano drug-delivery System With Cancer Immunotherapy
Takashi Nakamura, Hideyoshi Harashima · 2017 · Therapeutic Delivery
The cellular metabolic landscape in the tumor milieu regulates the activity of myeloid infiltrates
Eslam T. Mohamed, Amir A. Al-Khami, Paulo C. Rodrı́guez · 2018 · Cellular and Molecular Immunology
Checks and Balances in Autoimmune Vasculitis
Rebeca Hid Cadena, Wayel Habib Abdulahad, Geke A.P. Hospers, Thijs T. Wind, Annemieke M. H. Boots, Peter Heeringa, Elisabeth Brouwer · 2018 · Frontiers in Immunology
The Effect of Light Exposure at Night (LAN) on Carcinogenesis via Decreased Nocturnal Melatonin Synthesis
Aldo Giudice, Anna Crispo, Maria Grimaldi, Andrea Polo, Sabrina Bimonte, Mario Capunzo, Alfonso Amore, Giovanni Francesco D'Arena, Pellegrino Cerino, Alfredo Budillon et al. · 2018 · Molecules
Indoleamine 2,3-Dioxygenase Expression Pattern in the Tumor Microenvironment Predicts Clinical Outcome in Early Stage Cervical Cancer
Anne Marijne Heeren, Ilse van Dijk, Daniella R. A. I. Berry, Maryam Khelil, Debbie M. Ferns, Jeroen Kole, René J.P. Musters, Victor L. Thijssen, Constantijne Helene Mom, Gemma G. Kenter et al. · 2018 · Frontiers in Immunology
PD-L1 and IDO1 expression and tumor-infiltrating lymphocytes in osteosarcoma patients: comparative study of primary and metastatic lesions
Yu Toda, Kenichi Kohashi, Yuichi Yamada, Masato Yoshimoto, Shin Ishihara, Yoshihiro Ito, Takeshi Iwasaki, Hidetaka Yamamoto, Yoshihiro Matsumoto, Yasuharu Nakashima et al. · 2020 · Journal of Cancer Research and Clinical Oncology
Discovery of indoximod prodrugs and characterization of clinical candidate NLG802
Sanjeev Kumar, Firoz Ali Jaipuri, Jesse P. Waldo, Hima Potturi, Agnieszka Marcinowicz, James Adams, Clarissa Van Allen, Hong Zhuang, Nicholas N. Vahanian, Charles Link et al. · 2020 · European Journal of Medicinal Chemistry
Differential Gene Set Enrichment Analysis: a statistical approach to quantify the relative enrichment of two gene sets
James H. Joly, William E. Lowry, Nicholas Alexander Graham · 2020 · Bioinformatics
Discovery and structure-activity relationship studies of 1-aryl-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione derivatives as potent dual inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1) and trytophan 2,3-dioxygenase (TDO)
Shulei Pan, Yangli Zhou, Qiusheng Wang, Yanlin Wang, Chenyu Tian, Tianqi Wang, Luyi Huang, Jinshan Nan, Linli Li, Shengyong Yang · 2020 · European Journal of Medicinal Chemistry
The Molecular and Microenvironmental Landscape of Glioblastomas: Implications for the Novel Treatment Choices
Federica Di Cintio, Michele Dal Bo, Lorena Baboçi, Elena De Mattia, Maurizio Polano, Giuseppe Toffoli · 2020 · Frontiers in Neuroscience
Involvement of Kynurenine Pathway in Hepatocellular Carcinoma
Shivani Krishnamurthy, David Gilot, Seong Beom Ahn, Vincent K. L. Lam, Joo‐Shik Shin, Gilles J. Guillemin, Benjamin Heng · 2021 · Cancers
Barriers to Immunotherapy in Ovarian Cancer: Metabolic, Genomic, and Immune Perturbations in the Tumour Microenvironment
Racheal Louise Johnson, Michele Cummings, Amudha Thangavelu, Georgios Theophilou, Diederick De Jong, Nicolas Michel Orsi · 2021 · Cancers
An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells
Ivana Campia, Ilaria Buondonno, Barbara Castella, Barbara Rolando, Joanna Kopecka, Elena Gazzano, Dario Ghigo, Chiara Riganti · 2015 · PLoS ONE
Efficient tryptophan‐catabolizing activity is consistently conserved through evolution of TDO enzymes, but not IDO enzymes
Hajime Julie Yuasa, Helen J. Ball · 2015 · Journal of Experimental Zoology Part B Molecular and Developmental Evolution
Identification of genetic variants in the human indoleamine 2,3-dioxygenase (IDO1) gene, which have altered enzyme activity
Million Arefayene, Santosh Philips, Donghua Cao, SudhaRani Mamidipalli, Zeruesenay Desta, David Alastair Flockhart, David S. Wilkes, Todd C. Skaar · 2009 · Pharmacogenetics and Genomics
Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer
Niels Junker, Mads Hald Andersen, Lynn Wenandy, Sarah Louise Dombernowsky, Katalin Kiss, Christian Hjort Sørensen, Marianne Hamilton Therkildsen, Christian von Buchwald, Elo Andersen, Per thor Straten et al. · 2011 · Cytotherapy
Prognostic value of indoleamine 2,3-dioxygenase activity and expression in nasopharyngeal carcinoma
Ahlem Ben‐Haj‐Ayed, Adnène Moussa, Randa Ghedira, Sallouha Gabbouj, Souad Miled, Nadia Bouzid, Sameh Tebra-Mrad, Noureddine Bouaouina, Lotfi Chouchane, Abdelfattah Zakhama et al. · 2015 · Immunology Letters
Lambda phage nanoparticles displaying HER2-derived E75 peptide induce effective E75-CD8+ T response
Atefeh Arab, Jessica Nicastro, Roderick Adrian Slavcev, Atefeh P. Razazan, Nastaran Barati, Amin Reza Nikpoor, Amir Abbas Momtazi‐Borojeni, Fatemeh Mosaffa, Ali Badiee, Mahmoud Reza Jaafari et al. · 2017 · Immunologic Research
New 4‐Amino‐1,2,3‐Triazole Inhibitors of Indoleamine 2,3‐Dioxygenase Form a Long‐Lived Complex with the Enzyme and Display Exquisite Cellular Potency
Julie A. C. Alexandre, Michael Kenneth Swan, Mike John Latchem, Dean Boyall, John Robert Pollard, Stuart Wynn Hughes, James Westcott · 2017 · ChemBioChem
Dendritic cell subsets in childhood and in children with cancer: relation to age and disease prognosis
Jukka Vakkila, Angus W. Thomson, Kim K. Vettenranta, Hannu V. Sariola, U M Saarinen-Pihkala · 2004 · Clinical & Experimental Immunology
Interleukin-17 and type 17 helper T cells in cancer management and research
Franck Housseau, Abby L. Geis, Erik Thiele Orberg, Nicolas Jose Llosa · 2014 · ImmunoTargets and Therapy
From Genotype to Functional Phenotype: Unraveling the Metabolomic Features of Colorectal Cancer
Oliver F. Bathe, Farshad Farshidfar · 2014 · Genes
Serum Metabolomics Study of the Acute Graft Rejection in Human Renal Transplantation Based on Liquid Chromatography–Mass Spectrometry
Xinjie Zhao, Jihong Chen, Lei Ye, Guowang Xu · 2014 · Journal of Proteome Research
‘Off-the-shelf’ immunotherapy with iPSC-derived rejuvenated cytotoxic T lymphocytes
Miki Ando, Hiromitsu Nakauchi · 2016 · Experimental Hematology
Mechanism and prognostic value of indoleamine 2,3‐dioxygenase 1 expressed in hepatocellular carcinoma
Shaolong Li, Xue Han, Ning Lyu, Qiankun Xie, Haijing Deng, Luwen Mu, Tao Pan, Xin Huang, Xia Wang, Yuanyuan Shi et al. · 2018 · Cancer Science
Structural Basis of Inhibitor Selectivity in Human Indoleamine 2,3-Dioxygenase 1 and Tryptophan Dioxygenase
Khoa Pham, Ariel Lewis-Ballester, Syun‐Ru Yeh · 2019 · Journal of the American Chemical Society
Dysregulation at multiple points of the kynurenine pathway is a ubiquitous feature of renal cancer: implications for tumour immune evasion
Nick Hornigold, Karen R. Dunn, Rachel A. Craven, Alexandre Zougman, Sebastian Trainor, Rebecca Louise Shreeve, Joanne Brown, Helen Sewell, Michael Shires, Margaret A. Knowles et al. · 2020 · British Journal of Cancer
IDO1+ Paneth cells promote immune escape of colorectal cancer
Sandra Pflügler, Jasmin Svinka, Irene Scharf, Ilija Crnčec, Martin Filipits, Pornpimol Charoentong, Markus Tschurtschenthaler, Lukas Kenner, Monira Awad, Judith Stift et al. · 2020 · Communications Biology
Optimization of the Enrichment of Circulating Tumor Cells for Downstream Phenotypic Analysis in Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-1 Immunotherapy
Maria A. Papadaki, Afroditi Sotiriou, Christina Vasilopoulou, Maria Filika, Despoina Aggouraki, Panormitis G Tsoulfas, Christina A Apostolopoulou, Konstantinos Rounis, Dimitriοs Mavroudis, Sofia Agelaki · 2020 · Cancers